Abstract
The transmembrane protein-tyrosine phosphatase (PTP) DEP-1 (density-enhanced phosphatase) is a candidate tumor suppressor in the colon epithelium. We have explored the function of DEP-1 in colon epithelial cells by inducible re-expression in a DEP-1-deficient human colon cancer cell line. Density-enhanced phosphatase-1 re-expression led to profound inhibition of cell proliferation and cell migration, and was associated with cytoskeletal rearrangements. These effects were dependent on the PTP activity of DEP-1 as they were not observed with cells expressing the catalytically inactive DEP-1 C1239S variant. shRNA-mediated suppression of DEP-1 in a colon epithelial cell line with high endogenous DEP-1 levels enhanced proliferation, further supporting the antiproliferative function of DEP-1. Nutrients, which are considered to be chemoprotective with respect to colon cancer development, including butyrate, green tea and apple polyphenols, had the capacity to elevate transcription of endogenous DEP-1 mRNA and expression of DEP-1 protein. Upregulation of DEP-1 expression, and in turn inhibition of cell growth and migration may present a previously unrecognized mechanism of chemoprevention by nutrients.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenocarcinoma / enzymology
-
Adenocarcinoma / pathology*
-
Adenoma / enzymology
-
Adenoma / pathology*
-
Anticarcinogenic Agents / pharmacology*
-
Butyrates / pharmacology
-
Cell Division / drug effects
-
Cell Line, Tumor / cytology
-
Cell Line, Tumor / drug effects
-
Cell Line, Tumor / enzymology
-
Cell Movement / drug effects
-
Cells, Cultured / cytology
-
Cells, Cultured / drug effects
-
Cells, Cultured / enzymology
-
Chemokine CXCL12
-
Chemokines, CXC / pharmacology
-
Colon / cytology*
-
Colon / enzymology
-
Colonic Neoplasms / enzymology
-
Colonic Neoplasms / pathology*
-
Down-Regulation
-
Enzyme Induction / drug effects
-
Epithelial Cells / cytology
-
Epithelial Cells / drug effects*
-
Epithelial Cells / enzymology
-
Flavonoids / pharmacology
-
Humans
-
Lysophospholipids / pharmacology
-
Malus / chemistry
-
Neoplasm Proteins / biosynthesis
-
Neoplasm Proteins / genetics
-
Neoplasm Proteins / physiology*
-
Phenols / pharmacology
-
Plant Extracts / pharmacology
-
Polyphenols
-
Protein Phosphatase 1
-
Protein Tyrosine Phosphatases / biosynthesis
-
Protein Tyrosine Phosphatases / genetics
-
Protein Tyrosine Phosphatases / physiology*
-
RNA Interference
-
RNA, Messenger / biosynthesis
-
RNA, Messenger / genetics
-
RNA, Neoplasm / biosynthesis
-
RNA, Neoplasm / genetics
-
RNA, Small Interfering / pharmacology
-
Receptor-Like Protein Tyrosine Phosphatases, Class 3
-
Recombinant Fusion Proteins / biosynthesis
-
Recombinant Fusion Proteins / genetics
-
Tea / chemistry
-
Transcription, Genetic / drug effects
-
Transfection
-
Up-Regulation / drug effects
Substances
-
Anticarcinogenic Agents
-
Butyrates
-
CXCL12 protein, human
-
Chemokine CXCL12
-
Chemokines, CXC
-
Flavonoids
-
Lysophospholipids
-
Neoplasm Proteins
-
Phenols
-
Plant Extracts
-
Polyphenols
-
RNA, Messenger
-
RNA, Neoplasm
-
RNA, Small Interfering
-
Recombinant Fusion Proteins
-
Tea
-
Protein Phosphatase 1
-
PTPRJ protein, human
-
Protein Tyrosine Phosphatases
-
Receptor-Like Protein Tyrosine Phosphatases, Class 3
-
lysophosphatidic acid